Agenda of the PRAC meeting 1-4 September 2025
Submitted by Anonymous (not verified) on 1 September 2025 - 15:45
Agenda of the PRAC meeting 1-4 September 2025
Veterinary medicines European public assessment report (EPAR): Bravecto CombiUNO, fluralaner,milbemycin oxime, Status: Authorised
Submitted by Anonymous (not verified) on 1 September 2025 - 15:40
Veterinary medicines European public assessment report (EPAR): Bravecto CombiUNO, fluralaner,milbemycin oxime, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Zenrelia, ilunocitinib, Status: Authorised
Submitted by Anonymous (not verified) on 1 September 2025 - 15:40
Veterinary medicines European public assessment report (EPAR): Zenrelia, ilunocitinib, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Numelvi, atinvicitinib, Status: Authorised
Submitted by Anonymous (not verified) on 1 September 2025 - 15:30
Veterinary medicines European public assessment report (EPAR): Numelvi, atinvicitinib, Status: Authorised
Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 33, Status: Withdrawn
Submitted by Anonymous (not verified) on 1 September 2025 - 14:45
Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 33, Status: Withdrawn
EMA and WHO mark ten years of collaboration to advance global access to medicines
Submitted by Anonymous (not verified) on 1 September 2025 - 13:55
EMA and WHO mark ten years of collaboration to advance global access to medicines
World Health Organization (WHO)
Submitted by Anonymous (not verified) on 1 September 2025 - 13:52
World Health Organization (WHO)
Infosheet: European Medicines Agency - World Health Organization collaboration and partnership
Submitted by Anonymous (not verified) on 1 September 2025 - 13:51
Infosheet: European Medicines Agency - World Health Organization collaboration and partnership
Transfer of data on suspected adverse reactions to WHO
Submitted by Anonymous (not verified) on 1 September 2025 - 13:49
Transfer of data on suspected adverse reactions to WHO
Applications for new human medicines under evaluation: September 2025
Submitted by Anonymous (not verified) on 1 September 2025 - 12:46
Applications for new human medicines under evaluation: September 2025